About us
IQ Corporation is a global biopharmaceutical company based in The Netherlands. It is IQ‘s mission to contribute to human healthcare by the development and world-wide commercialization of innovative products for diagnosis and therapy.
IQ ProductsIn the past few years IQ has established a profitable specialized diagnostic business unit named IQ Products with world-wide sales. Focus areas are transplant related diagnosis, sepsis and perinatal diagnosis. New products are developed in-house and in close cooperation with international universities and innovative companies in order to rapidly expand our business. IQ Products has direct sales in the Netherlands and Germany and a worldwide network of distributors in over 45 countries.
IQ Therapeutics
Our therapeutic business unit IQ Therapeutics aims to deliver “Instant Immunity” based on its novel and proprietary human antibody-based technology. Focus is on biodefense and infectious disease applications with IQ-DAA as our lead product for treatment of Anthrax infections. IQ-DAA is currently in clinical phase I.